Cardiovascular Complications in Lupus Patients in the Aseer Region, Saudi Arabia

Nouf A Alhammadi1, Hanan Alqahtani2, Leinah H Alshahrani3

  • 1Rheumatology, King Khalid University, Abha, SAU.

Cureus
|September 18, 2023
PubMed

Insights

Cardiovascular complications affect 18% of Systemic Lupus Erythematosus (SLE) patients in Saudi Arabia, with coronary artery disease and myocardial infarction being common. Early detection and management are vital for improving patient outcomes.

Area of Science:

  • Rheumatology
  • Cardiology
  • Public Health

Background:

  • Systemic lupus erythematosus (SLE) is a significant autoimmune disease associated with high morbidity.
  • Cardiovascular complications represent a major concern in SLE patient management.

Purpose of the Study:

  • To determine the prevalence of cardiovascular complications in SLE patients.
  • To identify the types of cardiovascular complications observed in this population.
  • To investigate these factors within the Aseer region of Saudi Arabia.

Main Methods:

  • Retrospective record-based study conducted at Aseer Central Hospital.
  • Data collected from patients diagnosed with SLE between 2020 and 2022.
  • Comprehensive review of patient medical records.

Main Results:

  • 18.0% (34/189) of SLE patients experienced cardiovascular complications.
  • Common complications included coronary artery disease (38.2%), myocardial infarction (20.6%), pericarditis (14.7%), and myocarditis (14.7%).
  • Associated factors included hypertension (50.0%), vasculitis (38.2%), and diabetes (17.65%).

Conclusions:

  • Cardiovascular complications are prevalent in SLE patients in the Aseer region.
  • Understanding these complications is essential for healthcare providers.
  • Tailored treatment and preventive strategies are crucial for managing cardiovascular risks in SLE.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
12
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
16
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
18
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
287
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
436